In the current investigation we have extended and built upon our previous findings (2–4) highlighting a potential mechanism via which IL-6 mediated transcriptional imprinting of CD4+ T cells in the earliest stages of RA may programme effector responses of pathophysiological relevance. The gene discussed is CD4; the disease is rheumatoid arthritis.